Omaveloxolone | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Omaveloxolone
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Omaveloxolone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API

1 NDC API

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 1 FDA Orange Book, 1 Europe

2 FDF Dossiers
1 FDA Orange Book
1 Europe

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices, 1 Annual Reports

1 Finished Drug Prices
1 Annual Reports

PATENTS & EXCLUSIVITIES

8 US Patents, 2 US Exclusivities

8 US Patents
2 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8REATA PHARMS

filter Patent Number Reset all filters

8 All

01 18124799

02 18440854

03 18993640

04 19670147

05 19701709

06 111091430

07 211919838

filter API Patent Reset all filters

8 All

01 4Y

02 4Blank

filter FDF Patent Reset all filters

8 All

01 3Y

02 5Blank

filter Expiration Date Reset all filters

8 All

01 52029-04-20

02 12029-12-03

03 22033-04-24

Product Main Page

01

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-20

OMAVELOXOLONE

US Patent Number : 11091430

Drug Substance Claim :

Drug Product Claim :

Application Number : 216718

Patent Use Code : U-3552

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-20

Portfolio PDF

Product Web Link

Digital Content

02

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-20

OMAVELOXOLONE

US Patent Number : 11919838

Drug Substance Claim :

Drug Product Claim :

Application Number : 216718

Patent Use Code : U-3862

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-20

Portfolio PDF

Product Web Link

Digital Content

03

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-20

OMAVELOXOLONE

US Patent Number : 11919838

Drug Substance Claim :

Drug Product Claim :

Application Number : 216718

Patent Use Code : U-3863

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-20

Portfolio PDF

Product Web Link

Digital Content

04

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-04-24

OMAVELOXOLONE

US Patent Number : 9701709

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216718

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-24

Portfolio PDF

Product Web Link

Digital Content

05

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-20

OMAVELOXOLONE

US Patent Number : 9670147

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 216718

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-20

Portfolio PDF

Product Web Link

Digital Content

06

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-04-20

OMAVELOXOLONE

US Patent Number : 8440854

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216718

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-20

Portfolio PDF

Product Web Link

Digital Content

07

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-04-24

OMAVELOXOLONE

US Patent Number : 8993640

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 216718

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-24

Portfolio PDF

Product Web Link

Digital Content

08

REATA PHARMS

BioAsia

Not Confirmed

REATA PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-12-03

OMAVELOXOLONE

US Patent Number : 8124799

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 216718

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-03

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!